Sept 12, 2017 (LBO) – Hemas Pharmaceuticals, a pharmaceutical importer and distributor in Sri Lanka, has ventured into regional shores with its entry into Myanmar to commence distribution operations as Hemas Mandalar Pharmaceuticals Ltd.
“Through Hemas Mandalar Pharmaceuticals, we will focus on adding value to the nation’s healthcare industry by exploring means of introducing new healthcare solutions to the people of Myanmar,” Ashwani Bagga, chief executive officer of Hemas Mandalar Pharmaceuticals Ltd said.
“In the process, it will create over 100 new job opportunities thus far in Myanmar and we intend to create many more job opportunities in the future as well.”
Hemas Mandalar Pharmaceuticals Ltd, in partnership with Family Mandalar Company, would serve as the main distribution point for multinational and other pharmaceutical manufacturers that would enable the supply of quality pharmaceutical products across Myanmar.
Commenting on the strategic move, Group Chief Executive Officer of Hemas Holdings PLC, Steven Enderby said, Myanmar has been a core part of Hemas Pharmaceutical’s vision to expand regionally, a venture that we have been actively and energetically pursuing over the last three years.
“It was therefore important to us to partner with a well-established and reputed organisation such as the Family Mandalar Company with values that are aligned with ours to take on the challenging task of expanding our distribution operations beyond our own borders.”
Hemas Mandalar Pharmaceuticals Ltd will engage its core strengths of an extensive distribution network, well trained and highly experienced sales team, and the usage of real time sales data to ensure a smooth and efficient flow of operations in Myanmar.
Hemas Pharmaceuticals is one of the leading pharmaceutical distribution companies in Sri Lanka with a 17.55 percent market share having partnered with international pharmaceutical manufacturers.